(Q)SAR Modeling and Safety Assessment in Regulatory Review

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|91|3|529-534

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.3, 2012-03, pp. : 529-534

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Physiologically Based Pharmacokinetic Modeling in Regulatory Review

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 542-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review

By  

Current Drug Safety, Vol. 10, Iss. 3, 2015-01 ,pp. : 234-250

Bentham Science Publishers

Access to resources Recommend Favorite

The Practicing Clinician and Regulatory Safety Concerns

By  

Current Drug Safety, Vol. 8, Iss. 1, 2013-02 ,pp. : 17-24

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory review time and post‐market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross‐sectional study

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 716-726

John Wiley & Sons Inc

Access to resources Recommend Favorite

Regulatory review time and post‐market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross‐sectional study

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 716-726

John Wiley & Sons Inc

Access to resources Recommend Favorite